All News
JAK inhibitors in GCA?
The SELECT-GCA study, looking at upadacitinib in GCA, anchored the ACR 2024 opening plenary for a reason - it is highly notable and badly needed.
Read Article
Links:
Links:
Janet Pope Janetbirdope ( View Tweet)
Links:
Antoni Chan MD (Prof) synovialjoints ( View Tweet)
Links:
Links:
Links:
Impressive Plenary @andreafava just finished Novel urine protein panel id 12 proteins that predict NIH activity on renal bx better than existing options Improving at 3 mos predicts response at 1 year Could reduce biopsies / modulate tx! #ACR24 @RheumNow Abstr#1642 #ACRbest https://t.co/Gi6u6hAGzj
Links:
Mike Putman EBRheum ( View Tweet)
Antoni Chan MD (Prof) synovialjoints ( View Tweet)
Links:
Links:


